Home › Funds › John Hancock › Small Cap Stock Trust
Fund family: John Hancock · Filed by JOHN HANCOCK VARIABLE INSURANCE TRUST (CIK 756913) · SEC series S000008343
Share classes and tickers: JAGPX (C000022831), JAGQX (C000022833), JESGX (C000022832)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 757 with, 4 against, 14 abstentions (not counted as with management); 6 items carried no recommendation. Shareholder proposals: 4 FOR, 0 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as John Hancock’s manager page (290,519 ballot items across 99 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | John Hancock | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 95.0% | 736 | 90.1% | 242,172 |
| Backed environmental and social shareholder proposals at US companies | n/a | 0 | 13.4% | 1,935 |
Each ballot item this fund voted is set against the votes of the other John Hancock funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most John Hancock funds on 115 items (16.3% of the 704 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most John Hancock funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| VIPER ENERGY, INC. | 2026-05-19 | The approval, on an advisory basis, of the compensation of the Company's named executive officers. | For | AGAINST — 9 of 9 John Hancock funds | For | Approved, 86.8% support |
| SANMINA CORPORATION | 2026-03-09 | Shareholder To consider and vote upon the stockholder proposal entitled ''Independent Board Chairman,'' requesting that the Board of Directors adopt a policy and amend governing documents as necessary in order that two separate people hold the office of the Chairman and the office of the CEO. | For | AGAINST — 8 of 8 John Hancock funds | Against | — |
| SANMINA CORPORATION | 2026-03-09 | To elect eight directors of Sanmina Corporation: Krish Prabhu | Against | FOR — 8 of 8 John Hancock funds | Against | Passed (calculated), 93.9% support |
| AXSOME THERAPEUTICS, INC. | 2026-06-05 | DIRECTOR: Mark Saad | For | ABSTAIN — 8 of 8 John Hancock funds | For | — |
| AXSOME THERAPEUTICS, INC. | 2026-06-05 | DIRECTOR: Susan Mahony, PhD., MBA | For | ABSTAIN — 8 of 8 John Hancock funds | For | — |
| WINGSTOP INC. | 2026-05-21 | Approve, on an advisory basis, the compensation of the Company's named executive officers. | For | AGAINST — 8 of 8 John Hancock funds | For | Approved, 50.4% support |
| COMFORT SYSTEMS USA, INC. | 2026-05-18 | DIRECTOR: William J. Sandbrook | Abstain | FOR — 7 of 7 John Hancock funds | Against | — |
| CASELLA WASTE SYSTEMS, INC. | 2026-06-04 | To elect the following nominees as Class II directors of the Company to serve until the 2029 Annual Meeting of Stockholders: Emily Nagle Green | For | WITHHOLD — 7 of 7 John Hancock funds | For | Elected, 66.5% support |
| CASELLA WASTE SYSTEMS, INC. | 2026-06-04 | To elect the following nominees as Class II directors of the Company to serve until the 2029 Annual Meeting of Stockholders: Michael L. Battles | For | WITHHOLD — 7 of 7 John Hancock funds | For | Elected, 73.4% support |
| CARGURUS, INC. | 2026-06-03 | DIRECTOR: Langley Steinert | For | ABSTAIN — 7 of 7 John Hancock funds | For | — |
| CARGURUS, INC. | 2026-06-03 | DIRECTOR: Manik Gupta | For | ABSTAIN — 7 of 7 John Hancock funds | For | — |
| CLEAR SECURE, INC. | 2026-06-10 | Approval of, on an advisory basis, the compensation of our named executive officers. | For | AGAINST — 6 of 6 John Hancock funds | For | Approved, 95.4% support |
| HIMS & HERS HEALTH, INC. | 2026-06-11 | Advisory approval of the Company's executive compensation. | Against | FOR — 6 of 6 John Hancock funds | Against | Passed (calculated), 99.3% support |
| SCHOLAR ROCK HOLDING CORPORATION | 2026-06-04 | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. | For | AGAINST — 6 of 6 John Hancock funds | For | Approved, 61.7% support |
| UNIVERSAL DISPLAY CORPORATION | 2026-06-18 | Advisory resolution to approve the compensation of the Company's named executive officers. | For | AGAINST — 6 of 6 John Hancock funds | For | Passed (calculated), 80.4% support |
| CORE SCIENTIFIC, INC. | 2026-05-12 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. | For | AGAINST — 6 of 6 John Hancock funds | For | Approved, 63.7% support |
| ALIGNMENT HEALTHCARE INC | 2026-06-04 | Election of Directors David Hodgson | For | WITHHOLD — 6 of 6 John Hancock funds | For | — |
| ALIGNMENT HEALTHCARE INC | 2026-06-04 | Election of Directors Jacqueline Kosecoff | For | WITHHOLD — 6 of 6 John Hancock funds | For | — |
| ALIGNMENT HEALTHCARE INC | 2026-06-04 | Election of Directors Jody Bilney | For | WITHHOLD — 6 of 6 John Hancock funds | For | — |
| JAMES HARDIE INDUSTRIES PLC | 2025-10-29 | Increase Non-Executive Director Fee Pool | For | AGAINST — 5 of 5 John Hancock funds | — | — |
| IONQ, INC. | 2026-06-16 | To elect two Class II directors to hold office until our 2029 Annual Meeting of Stockholders and until a successor is duly elected and qualified or until earlier resignation or removal. Kathryn K. Chou | For | WITHHOLD — 5 of 5 John Hancock funds | For | — |
| PROTAGONIST THERAPEUTICS, INC. | 2026-06-17 | DIRECTOR: L.T. Williams, MD, PhD | For | ABSTAIN — 5 of 5 John Hancock funds | For | — |
| DIGITALOCEAN HOLDINGS, INC. | 2026-06-15 | Election of Class II Directors Pueo Keffer | For | WITHHOLD — 5 of 5 John Hancock funds | For | — |
| DIGITALOCEAN HOLDINGS, INC. | 2026-06-15 | Election of Class II Directors Warren Adelman | For | WITHHOLD — 5 of 5 John Hancock funds | For | — |
| PJT PARTNERS INC. | 2026-06-18 | To elect the three nominees for Class II directors listed below, each to serve for a three-year term expiring at the 2029 annual meeting of shareholders (Proposal 1): Thomas M. Ryan | For | WITHHOLD — 5 of 5 John Hancock funds | For | Passed (calculated), 84.6% support |
| Company | Meeting | Item | This fund | Most John Hancock funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| VERRA MOBILITY CORPORATION | 2026-05-19 | DIRECTOR: Patrick J. Byrne | Abstain | FOR — 5 of 5 John Hancock funds | Against | — |
| SITIME CORPORATION | 2026-05-29 | To approve, on an advisory basis, the compensation of SiTime's named executive officers as disclosed in SiTime's proxy statement. | For | AGAINST — 8 of 9 John Hancock funds | For | Approved, 82.1% support |
| MKS, INC. | 2026-05-11 | The approval, on an advisory basis, of a Company proposal to reduce the threshold percentage of shareholders required to call a special meeting of shareholders from 40% to 25%. | Abstain | FOR — 10 of 12 John Hancock funds | Against | Passed (calculated), 98.5% support |
| GLAUKOS CORPORATION | 2026-05-28 | DIRECTOR: Denice M. Torres | For | ABSTAIN — 4 of 4 John Hancock funds | For | — |
| PACS GROUP, INC. | 2026-06-10 | DIRECTOR: Evelyn Dilsaver | For | ABSTAIN — 4 of 4 John Hancock funds | For | — |
| EXLSERVICE HOLDINGS, INC. | 2026-06-16 | Election of Directors Kristy Pipes | Against | FOR — 4 of 4 John Hancock funds | Against | — |
| HIMS & HERS HEALTH, INC. | 2026-06-11 | DIRECTOR: Andrew Dudum | For | ABSTAIN — 4 of 4 John Hancock funds | For | — |
| HIMS & HERS HEALTH, INC. | 2026-06-11 | DIRECTOR: Christopher Payne | For | ABSTAIN — 4 of 4 John Hancock funds | For | — |
| CORE SCIENTIFIC, INC. | 2026-05-12 | Election of Directors Eric Weiss | For | WITHHOLD — 4 of 4 John Hancock funds | For | — |
| CORE SCIENTIFIC, INC. | 2026-05-12 | Election of Directors Jeff Booth | For | WITHHOLD — 4 of 4 John Hancock funds | For | — |
| XENON PHARMACEUTICALS INC | 2026-06-02 | To approve the Corporation's 2026 Equity Incentive Plan; | For | AGAINST — 4 of 4 John Hancock funds | For | Approved, 68.0% support |
| THE VITA COCO COMPANY, INC. | 2026-06-03 | DIRECTOR: Kenneth Sadowsky | For | ABSTAIN — 4 of 4 John Hancock funds | For | — |
| VIRIDIAN THERAPEUTICS, INC. | 2026-06-02 | To elect the two Class II director nominees to serve until the 2029 Annual Meeting of Stockholders, and until their successors are duly elected and qualified. Tomas Kiselak | Withhold | FOR — 4 of 4 John Hancock funds | Against | — |
| CELCUITY INC. | 2026-05-14 | DIRECTOR: David F. Dalvey | For | ABSTAIN — 4 of 4 John Hancock funds | For | — |
| CELCUITY INC. | 2026-05-14 | DIRECTOR: Polly A. Murphy | For | ABSTAIN — 4 of 4 John Hancock funds | For | — |
| CELCUITY INC. | 2026-05-14 | DIRECTOR: Richard E. Buller | For | ABSTAIN — 4 of 4 John Hancock funds | For | — |
| CELCUITY INC. | 2026-05-14 | To approve the Celcuity Inc. Amended and Restated Employee Stock Purchase Plan. | Against | FOR — 4 of 4 John Hancock funds | Against | — |
| CALIX, INC. | 2026-05-14 | To approve 672,300 shares of common stock reserved for issuance for the matching component of the Calix, Inc. Stock Purchase and Matching Plan. | For | AGAINST — 4 of 4 John Hancock funds | For | Passed (calculated), 81.5% support |
| GENEDX HOLDINGS CORP. | 2026-06-18 | DIRECTOR: Katherine Stueland | For | ABSTAIN — 4 of 4 John Hancock funds | For | — |
| GENIUS SPORTS LIMITED | 2025-12-10 | an ordinary resolution seeking approval of the re-appointment of Daniel Burns as a Class I Director of the Company for a term of three years to expire at the third annual general meeting of the Company's shareholders following such election and until he ceases to serve in his office in accordance wi | For | AGAINST — 4 of 4 John Hancock funds | For | — |
| AMERESCO, INC. (AMRC) | 2026-06-04 | Elect two (2) directors to the Ameresco, Inc. Board of Directors for a three-year term or until their successors are elected and qualified. Claire Hughes-Johnson | For | WITHHOLD — 4 of 4 John Hancock funds | For | — |
| AMERESCO, INC. (AMRC) | 2026-06-04 | Elect two (2) directors to the Ameresco, Inc. Board of Directors for a three-year term or until their successors are elected and qualified. Frank V. Wisneski | For | WITHHOLD — 4 of 4 John Hancock funds | For | — |
| AMERESCO, INC. (AMRC) | 2026-06-04 | To approve an amendment to Ameresco's 2020 Stock Incentive Plan (''Plan'') to increase the number of shares of Ameresco, Inc. Class A Common Stock authorised for issuance under the Plan by 3,200,000 from 5,000,000 to 8,200,000 as described in the Ameresco, Inc. Proxy Statement. | For | AGAINST — 4 of 4 John Hancock funds | For | — |
| BLOOM ENERGY CORPORATION | 2026-05-21 | DIRECTOR: Barbara Burger | For | ABSTAIN — 6 of 7 John Hancock funds | For | — |
| BLOOM ENERGY CORPORATION | 2026-05-21 | DIRECTOR: Eddy Zervigon | For | ABSTAIN — 6 of 7 John Hancock funds | For | — |
| NEXTRACKER INC. | 2025-08-18 | DIRECTOR: Jeffrey Guldner | For | ABSTAIN — 6 of 7 John Hancock funds | For | — |
| BRIDGEBIO PHARMA, INC. | 2026-06-22 | DIRECTOR: Hannah A. Valantine, MD | For | ABSTAIN — 6 of 7 John Hancock funds | For | — |
| BRIDGEBIO PHARMA, INC. | 2026-06-22 | To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 2,000,000 shares. | For | AGAINST — 6 of 7 John Hancock funds | For | Approved, 82.9% support |
| LIFE TIME GROUP HOLDINGS, INC. | 2026-04-22 | DIRECTOR: J. Kristofer Galashan | For | ABSTAIN — 8 of 10 John Hancock funds | For | — |
| LIFE TIME GROUP HOLDINGS, INC. | 2026-04-22 | DIRECTOR: Jennifer Pomerantz | For | ABSTAIN — 8 of 10 John Hancock funds | For | — |
| LIFE TIME GROUP HOLDINGS, INC. | 2026-04-22 | DIRECTOR: Jonathan Coslet | For | ABSTAIN — 8 of 10 John Hancock funds | For | — |
| CARGURUS, INC. | 2026-06-03 | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers for 2025. | Against | FOR — 6 of 7 John Hancock funds | Against | — |
| HAMILTON LANE INCORPORATED | 2025-09-04 | Advisory, non-binding vote to approve named executive officer compensation. | For | AGAINST — 7 of 9 John Hancock funds | For | Approved, 76.2% support |
| GLAUKOS CORPORATION | 2026-05-28 | Approval, on an advisory basis, of the compensation of the Company's named executive officers. | Against | FOR — 5 of 6 John Hancock funds | Against | Passed (calculated), 91.8% support |
| PACS GROUP, INC. | 2025-12-19 | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. | Against | FOR — 3 of 3 John Hancock funds | Against | — |
| LOAR HOLDINGS | 2026-06-02 | DIRECTOR: Alison Bomberg | For | ABSTAIN — 3 of 3 John Hancock funds | For | — |
| XOMETRY, INC. | 2026-06-16 | To elect three Class II directors, each to hold office until the Company's Annual Meeting of Stockholders in 2029. Fabio Rosati | For | WITHHOLD — 3 of 3 John Hancock funds | For | — |
| XOMETRY, INC. | 2026-06-16 | To elect three Class II directors, each to hold office until the Company's Annual Meeting of Stockholders in 2029. Katharine Weymouth | For | WITHHOLD — 3 of 3 John Hancock funds | For | — |
| RUSH ENTERPRISES, INC. | 2026-05-19 | DIRECTOR: Dr. Kennon H. Guglielmo | For | ABSTAIN — 5 of 6 John Hancock funds | For | — |
| RUSH ENTERPRISES, INC. | 2026-05-19 | DIRECTOR: Raymond J. Chess | For | ABSTAIN — 5 of 6 John Hancock funds | For | — |
| RUSH ENTERPRISES, INC. | 2026-05-19 | DIRECTOR: Troy A. Clarke | For | ABSTAIN — 5 of 6 John Hancock funds | For | — |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | 2026-06-05 | To elect two Class I director nominees to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2029 annual meeting of shareholders. Robert Hershberg, PhD, MD | For | WITHHOLD — 3 of 3 John Hancock funds | For | — |
| ENPHASE ENERGY, INC. | 2026-05-13 | To approve an amendment and restatement of our 2021 Equity Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 2,000,000 shares. | For | AGAINST — 3 of 3 John Hancock funds | For | Approved, 78.7% support |
| AVEPOINT, INC. | 2026-05-05 | DIRECTOR: Jeff Epstein | For | ABSTAIN — 3 of 3 John Hancock funds | For | — |
| AGILYSYS, INC. | 2025-09-04 | Election of Directors: Donald A. Colvin | Against | FOR — 3 of 3 John Hancock funds | Against | Elected, 97.1% support |
| AMPLITUDE, INC. | 2026-06-09 | DIRECTOR: Catherine Wong | For | ABSTAIN — 3 of 3 John Hancock funds | For | — |
| AMPLITUDE, INC. | 2026-06-09 | DIRECTOR: Curtis Liu | For | ABSTAIN — 3 of 3 John Hancock funds | For | — |
| AMPLITUDE, INC. | 2026-06-09 | DIRECTOR: Pat Grady | For | ABSTAIN — 3 of 3 John Hancock funds | For | — |
| MINERALYS THERAPEUTICS, INC. | 2026-05-21 | 2 wordings Election of Class III directors for a three-year term to expire at the 2029 annual meeting of stockholders: Srinivas Akkaraju, M.D., Ph.D. | For | WITHHOLD — 3 of 3 John Hancock funds | For | Passed (calculated), 60.6% support |
| VOYAGER TECHNOLOGIES, INC. | 2026-05-29 | DIRECTOR: Marian Joh | For | ABSTAIN — 3 of 3 John Hancock funds | For | — |
| ZURN ELKAY WATER SOLUTIONS CORPORATION | 2026-04-30 | Advisory vote to approve the compensation of Zurn Elkay's named executive officers, as disclosed in "Compensation Discussion and Analysis" and "Executive Compensation" in the Proxy Statement. | Against | FOR — 6 of 8 John Hancock funds | Against | Passed (calculated), 87.6% support |
| JAMES HARDIE INDUSTRIES PLC | 2025-10-29 | Grant of Return on Capital Employed Restricted Stock Units to CEO | For | AGAINST — 4 of 5 John Hancock funds | For | — |
| JAMES HARDIE INDUSTRIES PLC | 2025-10-29 | To receive and consider the remuneration report for fiscal year 2025 | For | AGAINST — 4 of 5 John Hancock funds | For | — |
| PROTAGONIST THERAPEUTICS, INC. | 2026-06-17 | DIRECTOR: Dinesh V. Patel, Ph.D. | For | ABSTAIN — 4 of 5 John Hancock funds | For | — |
| PROTAGONIST THERAPEUTICS, INC. | 2026-06-17 | To approve the adoption of the Company's 2026 Equity Incentive Plan. | For | AGAINST — 4 of 5 John Hancock funds | For | Approved, 84.4% support |
| INTAPP, INC | 2025-11-18 | DIRECTOR: Beverly Allen | For | ABSTAIN — 4 of 5 John Hancock funds | For | — |
| INTAPP, INC | 2025-11-18 | DIRECTOR: Marie Wieck | For | ABSTAIN — 4 of 5 John Hancock funds | For | — |
| CRINETICS PHARMACEUTICALS, INC. | 2026-06-18 | To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders; Caren Deardorf | For | WITHHOLD — 4 of 5 John Hancock funds | For | — |
| CRINETICS PHARMACEUTICALS, INC. | 2026-06-18 | To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders; Stephanie S. Okey, M.S. | For | WITHHOLD — 4 of 5 John Hancock funds | For | — |
| NUVALENT, INC. | 2026-06-16 | Election of the following nominees as Class II directors: Michael L. Meyers, M.D., Ph.D. | For | WITHHOLD — 4 of 5 John Hancock funds | For | Elected, 81.5% support |
| HAMILTON LANE INCORPORATED | 2025-09-04 | DIRECTOR: Hartley R. Rogers | For | ABSTAIN — 5 of 7 John Hancock funds | For | — |
| STRIDE, INC. | 2025-12-04 | Approval, on a non-binding advisory basis, of the compensation of the named executive officers of the Company; | Against | FOR — 5 of 7 John Hancock funds | Against | Approved, 81.9% support |
| AMERICAN HEALTHCARE REIT, INC. | 2026-06-24 | For the election of Jeffrey T. Hanson, Danny Prosky, Mathieu B. Streiff, Scott A. Estes, Brian J. Flornes, Dianne Hurley, Marvin R. O'Quinn, Valerie Richardson and Wilbur H. Smith III to serve as Directors until the Annual Meeting of Stockholders of American Healthcare REIT, Inc. to be held in the y | For | WITHHOLD — 6 of 9 John Hancock funds | For | — |
| STANDARDAERO, INC. | 2026-06-25 | DIRECTOR: Douglas V. Brandely | For | ABSTAIN — 6 of 10 John Hancock funds | For | — |
| STANDARDAERO, INC. | 2026-06-25 | DIRECTOR: Stefan Weingartner | For | ABSTAIN — 6 of 10 John Hancock funds | For | — |
| STANDARDAERO, INC. | 2026-06-25 | DIRECTOR: Wendy M. Masiello | For | ABSTAIN — 6 of 10 John Hancock funds | For | — |
| REVOLUTION MEDICINES, INC. | 2026-06-18 | DIRECTOR: Alexis Borisy | For | ABSTAIN — 3 of 4 John Hancock funds | For | — |
| SPYRE THERAPEUTICS INC. | 2026-05-27 | DIRECTOR: Laurie Stelzer | For | ABSTAIN — 3 of 4 John Hancock funds | For | — |
| SCHOLAR ROCK HOLDING CORPORATION | 2026-06-04 | DIRECTOR: David Hallal | For | ABSTAIN — 3 of 4 John Hancock funds | For | — |
| SCHOLAR ROCK HOLDING CORPORATION | 2026-06-04 | DIRECTOR: Katie Peng | For | ABSTAIN — 3 of 4 John Hancock funds | For | — |
| SCHOLAR ROCK HOLDING CORPORATION | 2026-06-04 | DIRECTOR: Kristina Burow | For | ABSTAIN — 3 of 4 John Hancock funds | For | — |
| SCHOLAR ROCK HOLDING CORPORATION | 2026-06-04 | DIRECTOR: Michael Gilman | For | ABSTAIN — 3 of 4 John Hancock funds | For | — |
| COGENT BIOSCIENCES, INC. | 2026-06-09 | DIRECTOR: Arlene M. Morris | For | ABSTAIN — 3 of 4 John Hancock funds | For | — |
| COGENT BIOSCIENCES, INC. | 2026-06-09 | DIRECTOR: Dr. Chris Cain | For | ABSTAIN — 3 of 4 John Hancock funds | For | — |
| COGENT BIOSCIENCES, INC. | 2026-06-09 | DIRECTOR: Todd Shegog | For | ABSTAIN — 3 of 4 John Hancock funds | For | — |
| DIANTHUS THERAPEUTICS, INC. | 2026-05-21 | To elect Class II directors, to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Anne McGeorge | For | WITHHOLD — 3 of 4 John Hancock funds | For | — |
| DISC MEDICINE, INC. | 2026-06-18 | To elect each of the following Class III nominees to the Board of Directors as set forth below: Donald Nicholson, Ph.D. | For | WITHHOLD — 3 of 4 John Hancock funds | For | — |
| MBX BIOSCIENCES | 2026-06-04 | Election of two Class II Directors, each to serve until the Company's 2029 Annual Meeting of Stockholder and until such person's successor is duly elected and qualified, or until their earlier death, resignation or removal: Edward T. Mathers | For | WITHHOLD — 3 of 4 John Hancock funds | For | — |
| MBX BIOSCIENCES | 2026-06-04 | Election of two Class II Directors, each to serve until the Company's 2029 Annual Meeting of Stockholder and until such person's successor is duly elected and qualified, or until their earlier death, resignation or removal: Patrick J. Heron | For | WITHHOLD — 3 of 4 John Hancock funds | For | — |
| INNOVEX INTERNATIONAL, INC. | 2026-05-07 | To elect the nominees named in the Proxy Statement as directors to serve for a three-year term. John Lovoi | Against | FOR — 3 of 4 John Hancock funds | Against | — |
| VAXCYTE, INC. | 2026-06-15 | DIRECTOR: Halley Gilbert, J.D. | For | ABSTAIN — 5 of 9 John Hancock funds | For | — |
| VAXCYTE, INC. | 2026-06-15 | DIRECTOR: Olivier Brandicourt MD | For | ABSTAIN — 5 of 9 John Hancock funds | For | — |
| KYMERA THERAPEUTICS, INC. | 2026-06-24 | DIRECTOR: Bruce Booth, D.Phil. | For | ABSTAIN — 4 of 7 John Hancock funds | For | — |
| KYMERA THERAPEUTICS, INC. | 2026-06-24 | DIRECTOR: Elena Ridloff, CFA | For | ABSTAIN — 4 of 7 John Hancock funds | For | — |
| KYMERA THERAPEUTICS, INC. | 2026-06-24 | DIRECTOR: John Maraganore, Ph.D. | For | ABSTAIN — 4 of 7 John Hancock funds | For | — |
| KYMERA THERAPEUTICS, INC. | 2026-06-24 | DIRECTOR: Nello Mainolfi, Ph.D. | For | ABSTAIN — 4 of 7 John Hancock funds | For | — |
| RUBRIK, INC. | 2026-06-03 | DIRECTOR: Asheem Chandna | For | ABSTAIN — 2 of 3 John Hancock funds | For | — |
| LOAR HOLDINGS | 2026-06-02 | DIRECTOR: Margaret McGetrick | For | ABSTAIN — 2 of 3 John Hancock funds | For | — |
| LOAR HOLDINGS | 2026-06-02 | DIRECTOR: Raja Bobbili | For | ABSTAIN — 2 of 3 John Hancock funds | For | — |
| ENPHASE ENERGY, INC. | 2026-05-13 | DIRECTOR: Benjamin Kortlang | Abstain | FOR — 2 of 3 John Hancock funds | Against | — |
Download all 115 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 90.7% of this fund’s 775 such votes could be given a sector; the other 72 (9.3%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Health Care | 230 | 0 | 0.0% |
| Consumer Discretionary | 154 | 2 | 1.3% |
| Technology | 118 | 1 | 0.8% |
| Industrials | 68 | 1 | 1.5% |
| Finance | 60 | 0 | 0.0% |
| Real Estate | 35 | 0 | 0.0% |
| Energy | 19 | 0 | 0.0% |
| Utilities | 10 | 0 | 0.0% |
| Consumer Staples | 9 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 482 | 0 |
| Say-on-Pay | 118 | 0 |
| Audit-related | 110 | 0 |
| Corporate Governance | 35 | 2 |
| Compensation | 25 | 0 |
| Capital Structure | 16 | 0 |
| Other | 5 | 0 |
| Shareholder Rights and Defenses | 5 | 2 |
| Extraordinary Transactions | 1 | 0 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| XOMETRY, INC. | June 16, 2026 | $10M | 5 | 0 |
| AMERICAN HEALTHCARE REIT, INC. | June 24, 2026 | $6M | 11 | 0 |
| HINGE HEALTH, INC. | June 3, 2026 | $6M | 3 | 0 |
| THE VITA COCO COMPANY, INC. | June 3, 2026 | $6M | 5 | 0 |
| ZURN ELKAY WATER SOLUTIONS CORPORATION | April 30, 2026 | $6M | 5 | 0 |
| NEXTRACKER INC. | August 18, 2025 | $6M | 5 | 0 |
| LIFE TIME GROUP HOLDINGS, INC. | April 22, 2026 | $5M | 7 | 0 |
| MKS, INC. | May 11, 2026 | $5M | 8 | 1 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 11, 2026 | MKS, INC. | A shareholder proposal to reduce the threshold percentage of shareholders required to call a special meeting of shareholders from 40% to 10%, if properly presented at the meeting. Shareholder proposal | For | Against |
| June 16, 2026 | FIVE BELOW, INC. | Shareholder proposal requesting that provisions in the Company's governance documents requiring greater than a simple majority shareholder vote be changed to a simple majority vote standard. Shareholder proposal | For | Against |
| March 9, 2026 | SANMINA CORPORATION | To consider and vote upon the stockholder proposal entitled ''Independent Board Chairman,'' requesting that the Board of Directors adopt a policy and amend governing documents as necessary in order that two separate people hold the office of the Chairman and the office of the CEO. Shareholder proposal | For | Against |
| May 14, 2026 | CALIX, INC. | To hold an advisory vote on a stockholder proposal relating to a simple majority vote. Shareholder proposal | For | Against |
Meetings with a proxy contest or competing nominees (1 in 2025-2026), and how the fund voted the items on its ballot.
797 ballot items at 113 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Small Cap Stock Trust (JAGPX) voted at 113 shareholder meetings of 112 companies, on 797 ballot items in all. Where management made a recommendation, the fund followed it on 97.7% of the items and voted against it 4 times. Its most frequent area of disagreement was corporate governance (2 of its votes against management). It voted on 4 shareholder proposals. It voted FOR the board's own proposals more often than John Hancock's funds as a whole (95.0% against 90.1%). It voted differently from most John Hancock funds on 115 items. 1 of its meetings was contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of John Hancock’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.